These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 18342564
1. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D, Wszolek ZK, Vingerhoets FJ. Parkinsonism Relat Disord; 2008 Aug; 14(6):465-70. PubMed ID: 18342564 [Abstract] [Full Text] [Related]
2. PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E, Calne DB, Stoessl AJ. Neurology; 1999 Dec 10; 53(9):2097-102. PubMed ID: 10599788 [Abstract] [Full Text] [Related]
3. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Nygaard TG, Takahashi H, Heiman GA, Snow BJ, Fahn S, Calne DB. Ann Neurol; 1992 Nov 10; 32(5):603-8. PubMed ID: 1449240 [Abstract] [Full Text] [Related]
4. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, Healy DG, Gilks WP, Sweeney MG, Ganguly M, Gibbons V, Gandhi S, Vaughan J, Eunson LH, Katzenschlager R, Gayton J, Lennox G, Revesz T, Nicholl D, Bhatia KP, Quinn N, Brooks D, Lees AJ, Davis MB, Piccini P, Singleton AB, Wood NW. Brain; 2005 Dec 10; 128(Pt 12):2786-96. PubMed ID: 16272164 [Abstract] [Full Text] [Related]
5. Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions. Socal MP, Emmel VE, Rieder CR, Hilbig A, Saraiva-Pereira ML, Jardim LB. Parkinsonism Relat Disord; 2009 Jun 10; 15(5):374-8. PubMed ID: 18990604 [Abstract] [Full Text] [Related]
6. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ. Brain; 2005 Dec 10; 128(Pt 12):2777-85. PubMed ID: 16081470 [Abstract] [Full Text] [Related]
7. Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism. Garraux G, Caberg JH, Vanbellinghen JF, Jamar M, Bours V, Moonen G, Dive D. Arch Neurol; 2012 Mar 10; 69(3):398-400. PubMed ID: 22410449 [Abstract] [Full Text] [Related]
9. Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease. Bertoli-Avella AM, Giroud-Benitez JL, Bonifati V, Alvarez-Gonzalez E, Heredero-Baute L, van Duijn CM, Heutink P. Mov Disord; 2003 Nov 10; 18(11):1240-9. PubMed ID: 14639663 [Abstract] [Full Text] [Related]
10. Autosomal dominant familial Parkinson disease: older onset of age, and good response to levodopa therapy. Hasegawa K, Kowa H. Eur Neurol; 1997 Nov 10; 38 Suppl 1():39-43. PubMed ID: 9276200 [Abstract] [Full Text] [Related]
11. A family with hereditary juvenile dystonia-parkinsonism. Ishikawa A, Miyatake T. Mov Disord; 1995 Jul 10; 10(4):482-8. PubMed ID: 7565830 [Abstract] [Full Text] [Related]
12. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Kim JM, Hong S, Kim GP, Choi YJ, Kim YK, Park SS, Kim SE, Jeon BS. Arch Neurol; 2007 Oct 10; 64(10):1510-8. PubMed ID: 17923635 [Abstract] [Full Text] [Related]
13. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, Farrer M. Ann Neurol; 2005 May 10; 57(5):762-5. PubMed ID: 15852371 [Abstract] [Full Text] [Related]
19. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Sawle GV, Wroe SJ, Lees AJ, Brooks DJ, Frackowiak RS. Ann Neurol; 1992 Nov 15; 32(5):609-17. PubMed ID: 1449241 [Abstract] [Full Text] [Related]
20. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease. Torstenson R, Hartvig P, Långström B, Westerberg G, Tedroff J. Ann Neurol; 1997 Mar 15; 41(3):334-40. PubMed ID: 9066354 [Abstract] [Full Text] [Related] Page: [Next] [New Search]